Home › Hypoparathyroidism › New York
Hypoparathyroidism clinical trials in New York
3 studies for Hypoparathyroidism are looking for participants at sites in New York.
A Phase 3 Randomized Clinical Trial to Investigate the Safety and Efficacy of Palopegteriparatide at Doses Greater Than 30 μg/Day in Adult Participants With Hypoparathyroidism
- Ascendis Pharma Investigational Site, New York
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT07081997A Study to Investigate Canvuparatide Compared With Placebo in Adult Patients With Hypoparathyroidism
- MBX Biosciences Investigational Site, Albany
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT07699471Hypoparathyroidism Natural History Study
- Columbia University Medical Center - Harkness Pavillion, New York
RecruitingObservational studyHealthy volunteers welcome
Ages 18 to 100 · All sexes · Updated Dec 16, 2025 · NCT05793853From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.